{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:32:13Z","timestamp":1771234333607,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The aim of this study was to explore the long non-coding RNA (lncRNA) expression profiles in serum of patients with ankylosing spondylitis (AS). The role of these lncRNAs in this complex autoimmune situation needs to be evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We used high-throughput whole-transcriptome sequencing to generate sequencing data from three patients with AS and three normal controls (NC). Then, we performed bioinformatics analyses to identify the functional and biological processes associated with differentially expressed lncRNAs (DElncRNAs). We confirmed the validity of our RNA-seq data by assessing the expression of eight lncRNAs via quantitative reverse transcription polymerase chain reaction (qRT-PCR) in 20 AS and 20 NC samples. We measured the correlation between the expression levels of lncRNAs and patient clinical index values using the Spearman correlation test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 72 significantly upregulated and 73 significantly downregulated lncRNAs in AS patients compared to NC. qRT-PCR was performed to validate the expression of selected DElncRNAs; the results demonstrated that the expression levels of MALAT1:24, NBR2:9, lnc-DLK1-35:13, lnc-LARP1-1:1, lnc-AIPL1-1:7, and lnc-SLC12A7-1:16 were consistent with the sequencing analysis results. Enrichment analysis showed that DElncRNAs mainly participated in the immune and inflammatory responses pathways, such as regulation of protein ubiquitination, major histocompatibility complex class I-mediated antigen processing and presentation, MAPkinase activation, and interleukin-17 signaling pathways. In addition, a competing endogenous RNA network was constructed to determine the interaction among the lncRNAs, microRNAs, and mRNAs based on the confirmed lncRNAs (MALAT1:24 and NBR2:9). We further found the expression of MALAT1:24 and NBR2:9 to be positively correlated with disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Taken together, our study presents a comprehensive overview of lncRNAs in the serum of AS patients, thereby contributing novel perspectives on the underlying pathogenic mechanisms of this condition. In addition, our study predicted MALAT1 has the potential to be deeply involved in the pathogenesis of AS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-024-07396-z","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:42:54Z","timestamp":1713249774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification and bioinformatics analysis of lncRNAs in serum of patients with ankylosing spondylitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Jianqiang","family":"Kou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongchen","family":"Bie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"7396_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. The Lancet. 2007;369:1379\u201390.","journal-title":"The Lancet"},{"key":"7396_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/ar2722","volume":"11","author":"L Melis","year":"2009","unstructured":"Melis L, Elewaut D. Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease? Arthritis Res Ther. 2009;11:233.","journal-title":"Arthritis Res Ther"},{"key":"7396_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.berh.2006.03.001","volume":"20","author":"JA Smith","year":"2006","unstructured":"Smith JA, M\u00e4rker-Hermann E, Colbert RA. Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol. 2006;20:571\u201391.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"7396_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.7748\/ns2013.12.28.16.52.e7807","volume":"28","author":"D Bond","year":"2013","unstructured":"Bond D. Ankylosing spondylitis: diagnosis and management. Nurs Stand. 2013;28:52\u20139.","journal-title":"Nurs Stand"},{"key":"7396_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","volume":"57","author":"RA Colbert","year":"2014","unstructured":"Colbert RA, Tran TM, Layh-Schmitt G. HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol. 2014;57:44\u201351.","journal-title":"Mol Immunol"},{"key":"7396_CR6","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1136\/annrheumdis-2014-206323","volume":"74","author":"F Ciccia","year":"2015","unstructured":"Ciccia F, et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann Rheum Dis. 2015;74:1739\u201347.","journal-title":"Ann Rheum Dis"},{"key":"7396_CR7","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.9116","author":"M Tan","year":"2020","unstructured":"Tan M, et al. Autophagy dysfunction may be involved in the pathogenesis of ankylosing spondylitis. Exp Ther Med. 2020. https:\/\/doi.org\/10.3892\/etm.2020.9116.","journal-title":"Exp Ther Med"},{"key":"7396_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-981-10-5203-3_2","volume":"1008","author":"VS Akhade","year":"2017","unstructured":"Akhade VS, Pal D, Kanduri C. Long noncoding RNA: genome organization and mechanism of action. Springer Singapore. 2017;1008:47\u201374. https:\/\/doi.org\/10.1007\/978-981-10-5203-3_2.","journal-title":"Springer Singapore"},{"key":"7396_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2174\/1386207321666191010114149","volume":"22","author":"F Fattahi","year":"2019","unstructured":"Fattahi F, et al. Enrichment of up-regulated and down-regulated gene clusters using gene ontology, miRNAs and lncRNAs in colorectal cancer. Comb Chem High Throughput Screening. 2019;22:534\u201345.","journal-title":"Comb Chem High Throughput Screening"},{"key":"7396_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11010-019-03681-x","volume":"466","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang S, Zhang C, Wang M. LncRNA MEG3 inhibits the inflammatory response of ankylosing spondylitis by targeting miR-146a. Mol Cell Biochem. 2020;466:17\u201324.","journal-title":"Mol Cell Biochem"},{"key":"7396_CR11","doi-asserted-by":"publisher","first-page":"591706","DOI":"10.3389\/fimmu.2021.591706","volume":"12","author":"HC Yu","year":"2021","unstructured":"Yu HC, et al. Down-regulation of LOC645166 in T cells of ankylosing spondylitis patients promotes the NF-\u03baB signaling via decreasingly blocking recruitment of the IKK complex to K63-linked polyubiquitin chains. Front Immunol. 2021;12:591706.","journal-title":"Front Immunol"},{"key":"7396_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.omtn.2019.11.025","volume":"19","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. H19 Increases IL-17A\/IL-23 Releases via Regulating VDR by Interacting with miR675-5p\/miR22-5p in Ankylosing Spondylitis. Molr Ther Nucleic Acids. 2020;19:393\u2013404.","journal-title":"Molr Ther Nucleic Acids"},{"key":"7396_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"SVD Linden","year":"1984","unstructured":"Linden SVD, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27:361\u20138.","journal-title":"Arthritis Rheum"},{"key":"7396_CR14","doi-asserted-by":"publisher","first-page":"626878","DOI":"10.3389\/fcvm.2021.626878","volume":"8","author":"C Zhang","year":"2021","unstructured":"Zhang C, Wang H, Li J, Ma L. Circular RNA involvement in the protective effect of human umbilical cord mesenchymal stromal cell-derived extracellular vesicles against hypoxia\/reoxygenation injury in cardiac cells. Front Cardiovascular Med. 2021;8:626878.","journal-title":"Front Cardiovascular Med"},{"key":"7396_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"7396_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:1\u20136.","journal-title":"BMC Bioinformatics"},{"key":"7396_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"7396_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"7396_CR19","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2022","unstructured":"Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2022;51:D587\u201392.","journal-title":"Nucleic Acids Res"},{"key":"7396_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"7396_CR21","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1093\/nar\/gku631","volume":"42","author":"Y Ru","year":"2014","unstructured":"Ru Y, et al. The multiMiR R package and database: integration of microRNA\u2013target interactions along with their disease and drug associations. Nucleic Acids Res. 2014;42:e133\u2013e133.","journal-title":"Nucleic Acids Res"},{"key":"7396_CR22","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.rdc.2020.01.016","volume":"46","author":"J Ermann","year":"2020","unstructured":"Ermann J. Pathogenesis of axial spondyloarthritis \u2014 sources and current state of knowledge. Rheumatic Disease Clinics Of N.a America. 2020;46:193\u2013206.","journal-title":"Rheumatic Disease Clinics Of N.a. America"},{"key":"7396_CR23","doi-asserted-by":"publisher","first-page":"194419","DOI":"10.1016\/j.bbagrm.2019.194419","volume":"1863","author":"EK Robinson","year":"2020","unstructured":"Robinson EK, Covarrubias S, Carpenter S. The how and why of lncRNA function: An innate immune perspective. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2020;1863:194419.","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"key":"7396_CR24","doi-asserted-by":"publisher","first-page":"e03523","DOI":"10.7554\/eLife.03523","volume":"3","author":"J Ruiz-Orera","year":"2014","unstructured":"Ruiz-Orera J, Messeguer X, Subirana JA, Alba MM. Long non-coding RNAs as a source of new peptides. eLife. 2014;3:e03523.","journal-title":"eLife"},{"key":"7396_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.it.2014.07.005","volume":"35","author":"JA Heward","year":"2014","unstructured":"Heward JA, Lindsay MA. Long non-coding RNAs in the regulation of the immune response. Trends Immunol. 2014;35:408\u201319.","journal-title":"Trends Immunol"},{"key":"7396_CR26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1189\/jlb.0611316","volume":"90","author":"B Laugel","year":"2011","unstructured":"Laugel B, et al. The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells. J Leukoc Biol. 2011;90:1089\u201399.","journal-title":"J Leukoc Biol"},{"key":"7396_CR27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1084\/jem.191.4.661","volume":"191","author":"MJ Smyth","year":"2000","unstructured":"Smyth MJ, et al. Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells. J Exp Med. 2000;191:661\u20138.","journal-title":"J Exp Med"},{"key":"7396_CR28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.autrev.2013.04.001","volume":"12","author":"G Wildner","year":"2013","unstructured":"Wildner G, Kaufmann U. What causes relapses of autoimmune diseases? The etiological role of autoreactive T cells. Autoimmun Rev. 2013;12:1070\u20135.","journal-title":"Autoimmun Rev"},{"key":"7396_CR29","doi-asserted-by":"publisher","first-page":"102116","DOI":"10.1016\/j.jbc.2022.102116","volume":"298","author":"M Huang","year":"2022","unstructured":"Huang M, et al. miR-134-5p inhibits osteoclastogenesis through a novel miR-134-5p\/Itgb1\/MAPK pathway. J Biol Chem. 2022;298:102116.","journal-title":"J Biol Chem"},{"key":"7396_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11926-019-0856-3","volume":"21","author":"SJ Pedersen","year":"2019","unstructured":"Pedersen SJ, Maksymowych WP. The pathogenesis of ankylosing spondylitis: an update. Curr Rheumatol Rep. 2019;21:58.","journal-title":"Curr Rheumatol Rep"},{"key":"7396_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/art.40770","volume":"71","author":"MN Tok","year":"2019","unstructured":"Tok MN, et al. Interleukin-17A inhibition diminishes inflammation and new bone formation in experimental spondyloarthritis. Arthritis Rheumatol. 2019;71:612\u201325.","journal-title":"Arthritis Rheumatol"},{"key":"7396_CR32","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/cdd.2009.74","volume":"16","author":"H Huang","year":"2009","unstructured":"Huang H, et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ. 2009;16:1332\u201343.","journal-title":"Cell Death Differ"},{"key":"7396_CR33","doi-asserted-by":"publisher","first-page":"108878","DOI":"10.1016\/j.intimp.2022.108878","volume":"108","author":"Z Mahmoudi","year":"2022","unstructured":"Mahmoudi Z, et al. Efficacy of DMARDs and methylprednisolone treatment on the gene expression levels of HSPA5, MMD, and non-coding RNAs MALAT1, H19, miR-199a-5p, and miR-1-3p, in patients with rheumatoid arthritis. Int Immunopharmacol. 2022;108:108878.","journal-title":"Int Immunopharmacol"},{"key":"7396_CR34","first-page":"6881","volume":"24","author":"L Li","year":"2020","unstructured":"Li L, Ma X, Zhao YF, Zhang C. MiR-1\u20133p facilitates Th17\u00a0differentiation associating with multiple sclerosis via targeting ETS1. European Rev Med Pharmacolog Sci. 2020;24:6881\u201392.","journal-title":"European Rev Med Pharmacolog Sci"},{"key":"7396_CR35","doi-asserted-by":"publisher","first-page":"102510","DOI":"10.1016\/j.jaut.2020.102510","volume":"113","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang J, Luo S, Zhan Y, Lu Q. The roles of PPAR\u03b3 and its agonists in autoimmune diseases: a comprehensive review. J Autoimmun. 2020;113:102510.","journal-title":"J Autoimmun"},{"key":"7396_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-02149-4","volume":"22","author":"A Lin","year":"2020","unstructured":"Lin A, et al. Lipocalin 2 links inflammation and ankylosis in the clinical overlap of inflammatory bowel disease (IBD) and ankylosing spondylitis (AS). Arthritis Res Ther. 2020;22:1\u20131.","journal-title":"Arthritis Res Ther"},{"key":"7396_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s13018-023-03871-w","volume":"18","author":"Y Bie","year":"2023","unstructured":"Bie Y, et al. RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patients. J Orthopaedic Surg Res. 2023;18:394.","journal-title":"J Orthopaedic Surg Res"},{"key":"7396_CR38","doi-asserted-by":"publisher","first-page":"77400","DOI":"10.18632\/oncotarget.20490","volume":"8","author":"H Yang","year":"2017","unstructured":"Yang H, et al. Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus. Oncotarget. 2017;8:77400\u20136.","journal-title":"Oncotarget"},{"key":"7396_CR39","doi-asserted-by":"publisher","first-page":"C52","DOI":"10.1152\/ajpcell.00278.2017","volume":"315","author":"H-J Zhou","year":"2018","unstructured":"Zhou H-J, et al. Long noncoding RNA MALAT1 contributes to inflammatory response of microglia following spinal cord injury via the modulation of a miR-199b\/IKK\u03b2\/NF-\u03baB signaling pathway. Am J Physiol Cell Physiol. 2018;315:C52\u201361.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7396_CR40","first-page":"1536","volume":"41","author":"X Yang","year":"2018","unstructured":"Yang X, Zhang Y, Li Y, Wen T. MALAT1 enhanced the proliferation of human osteoblasts treated with ultra-high molecular weight polyethylene by targeting VEGF via miR-22\u20135p. Int J Mol Med. 2018;41:1536\u201346.","journal-title":"Int J Mol Med"},{"key":"7396_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00441-018-2963-2","volume":"376","author":"J Yi","year":"2018","unstructured":"Yi J, Liu D, Xiao J. LncRNA MALAT1 sponges miR-30 to promote osteoblast differentiation of adipose-derived mesenchymal stem cells by promotion of Runx2 expression. Cell Tissue Res. 2018;376:113\u201321.","journal-title":"Cell Tissue Res"},{"key":"7396_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.14348\/molcells.2022.2081","volume":"45","author":"W Chen","year":"2022","unstructured":"Chen W, Wang F, Wang J, Chen F, Chen T. The molecular mechanism of long non-coding RNA MALAT1-mediated regulation of chondrocyte pyroptosis in ankylosing spondylitis. Mol Cells. 2022;45:365\u201375.","journal-title":"Mol Cells"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-07396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-024-07396-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-024-07396-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T09:38:22Z","timestamp":1713346702000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-024-07396-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["7396"],"URL":"https:\/\/doi.org\/10.1186\/s12891-024-07396-z","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"8 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved and reviewed by the Medical Ethics Review Committee of the Affiliated Hospital of Qingdao University (approval number: QYFY WZLL 27251). A prior written informed consent was obtained from all the patients to participate in the study. All methods were carried out in accordance with relevant guidelines and regulations.<b>Consent for publication.<\/b>Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"291"}}